🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.7400
-0.0200 (-2.63%)
At close: Nov 20, 2026

Pharmaniaga Berhad Balance Sheet

Millions MYR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
53.2654.368.68114.7452.8547.11
Short-Term Investments
72.64223.2767.362.874.1110.25
Cash & Short-Term Investments
125.89277.57136.04117.6156.9657.36
Cash Growth
-63.42%104.04%15.67%106.48%-0.70%40.85%
Accounts Receivable
706.4324.55337.63285.22261.75227.85
Other Receivables
9.6897.5286.9884.476.7744.1
Receivables
716.08422.06424.6369.62338.52271.95
Inventory
748.38729.82612.79580.64767.261,264
Prepaid Expenses
-16.4911.0626.932.0627.52
Restricted Cash
-18.319.812.7--
Total Current Assets
1,5901,4641,2041,1071,1951,621
Property, Plant & Equipment
612.93602.78609.36605.75443.03395.59
Goodwill
76.977.0377.3177.4777.34129.48
Other Intangible Assets
11.9922.6528.2523.872.3975.31
Long-Term Deferred Tax Assets
70.0928.1527.3452.0848.8933.07
Long-Term Deferred Charges
74.5151.9745.7648.310.833.23
Total Assets
2,4372,2471,9921,9151,8472,258

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,064776.48650.1627.78648.02677.63
Accrued Expenses
0.3540.4796.1991.646.7831.53
Short-Term Debt
443.8527.49771.26711.18681.3543.98
Current Portion of Long-Term Debt
32.8162.55283.41335.87384.4525.7
Current Portion of Leases
2.273.994.484.625.671.57
Current Income Taxes Payable
7.086.9710.469.84.2714.44
Current Unearned Revenue
28.0111.6929.769.1631.2822.46
Other Current Liabilities
6.381.45107.43212.44265.93150.46
Total Current Liabilities
1,5851,6111,9532,0022,0681,468
Long-Term Debt
282.66125.4129.57138.6291.67284.99
Long-Term Leases
0.030.373.181.0950.62
Long-Term Unearned Revenue
19.4715.2214.513.13.363.62
Pension & Post-Retirement Benefits
9.4310.5610.7910.849.059.08
Long-Term Deferred Tax Liabilities
25.425.0527.1332.8518.8221.35
Other Long-Term Liabilities
12-----
Total Liabilities
1,9341,7882,1382,1892,1961,787

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
243.43243.43200.05200.05154.19154.05
Retained Earnings
148.2397.06-471.41-603.42-525.23293.73
Comprehensive Income & Other
86.1193.98100.09104.311.342.69
Total Common Equity
477.76434.47-171.28-299.07-369.69450.46
Minority Interest
25.0224.6925.3324.9821.3919.98
Shareholders' Equity
502.79459.16-145.94-274.09-348.31470.44
Total Liabilities & Equity
2,4372,2471,9921,9151,8472,258

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
761.56819.791,1921,1911,168856.86
Net Cash (Debt)
-635.67-542.22-1,056-1,074-1,111-799.5
Net Cash Growth
------
Net Cash Per Share
-0.48-0.75-3.66-3.93-4.24-3.05
Filing Date Shares Outstanding
1,3111,311288.25288.25262.04261.99
Total Common Shares Outstanding
1,3111,311288.25288.25262.04261.99
Working Capital
5.34-146.85-748.78-894.98-872.9153.43
Book Value Per Share
0.360.33-0.59-1.04-1.411.72
Tangible Book Value
388.87334.79-276.83-400.33-519.43245.68
Tangible Book Value Per Share
0.300.26-0.96-1.39-1.980.94
Land
-394.94393.11394.0125.6625.55
Buildings
----254.02255.22
Machinery
-503.78503.2497.02444.29430.76
Construction In Progress
-142.41125.81109.2875.4230.17